VanEck Associates’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.3M Sell
14,993
-1,501
-9% -$731K 0.01% 583
2025
Q1
$10.1M Buy
16,494
+1,353
+9% +$833K 0.01% 476
2024
Q4
$8.02M Buy
15,141
+3,531
+30% +$1.87M 0.01% 532
2024
Q3
$6.89M Buy
11,610
+3,043
+36% +$1.8M 0.01% 545
2024
Q2
$4.65M Buy
8,567
+1,416
+20% +$768K 0.01% 605
2024
Q1
$4.59M Buy
7,151
+2,788
+64% +$1.79M 0.01% 612
2023
Q4
$2.55M Buy
4,363
+811
+23% +$474K ﹤0.01% 739
2023
Q3
$1.85M Sell
3,552
-658
-16% -$342K ﹤0.01% 763
2023
Q2
$2.28M Buy
4,210
+72
+2% +$39K 0.01% 695
2023
Q1
$2.23M Buy
4,138
+1,529
+59% +$822K 0.01% 687
2022
Q4
$1.33M Sell
2,609
-5
-0.2% -$2.55K ﹤0.01% 747
2022
Q3
$1.14M Sell
2,614
-161
-6% -$70.3K ﹤0.01% 752
2022
Q2
$1.3M Sell
2,775
-230
-8% -$108K ﹤0.01% 745
2022
Q1
$1.52M Buy
3,005
+2,609
+659% +$1.32M ﹤0.01% 760
2021
Q4
$209K Buy
396
+16
+4% +$8.44K ﹤0.01% 1103
2021
Q3
$177K Sell
380
-1,380
-78% -$643K ﹤0.01% 1046
2021
Q2
$835K Buy
1,760
+198
+13% +$93.9K ﹤0.01% 827
2021
Q1
$718K Buy
1,562
+516
+49% +$237K ﹤0.01% 792
2020
Q4
$557K Buy
1,046
+698
+201% +$372K ﹤0.01% 763
2020
Q3
$167K Buy
+348
New +$167K ﹤0.01% 839